SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon recommends final dividend

26 Apr 2013 Evaluate

Biocon has informed that the Board of Directors of the Company at its meeting held on April 25, 2013 has recommended a final dividend of Rs. 5 per share (i.e. 100%) and a special dividend of Rs. 2.50 per share (i.e.50%) for the financial year 2012-13.

The declaration of dividend is subject to shareholders’ approval at the ensuing Annual General Meeting of the Company. Subsequent to Shareholders approval the dividend will be paid within a period of 30 days from the date of such approval.

The above information is a part of company’s filings submitted to BSE.

Biocon Share Price

362.50 4.30 (1.20%)
20-Apr-2026 12:57 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.35
Dr. Reddys Lab 1236.85
Cipla 1232.80
Zydus Lifesciences 942.40
Lupin 2332.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×